Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CRXM Gene Biotherapeutics

Watchlist
0.0000.0000.00%
Close  01/31 16:00 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.000
Volume
0.00
Market Cap
6.49K
P/E(TTM)
Loss
52wk High
0.000
Shares
64.93M
P/E(Static)
Loss
52wk Low
0.000
Float Cap
6.48K
Bid/Ask %
0.00%
Historical High
0.000
Shs Float
64.79M
Volume Ratio
0.00
Historical Low
0.000
Dividend TTM
--
Div Yield TTM
--
P/B
-0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Float Cap
6.48K
Bid/Ask %
0.00%
Historical High
0.000
Shs Float
64.79M
Volume Ratio
0.00
Historical Low
0.000
Dividend TTM
--
P/B
-0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Price Forecast

News

Comment

No More
Company Overview More
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company. The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease, and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde in December 2003 and is headquartered in San Diego, CA.
CEO: Mr. Christopher J. Reinhard
Market: Pink Market
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist